ATRA plus arsenic gets another "A" in APL Journal Article


Author: Park, J. H.
Article Title: ATRA plus arsenic gets another "A" in APL
Abstract: In this issue of Blood, Iland et al report that the addition of arsenic trioxide during induction and consolidation can substantially reduce the amount of chemotherapy and the duration of consolidation to achieve excellent outcomes in patients with newly diagnosed acute promyelocytic leukemia (APL; see figure). (Figure Presented).
Keywords: cancer survival; treatment outcome; treatment response; survival rate; note; disease free survival; methotrexate; follow up; arsenic trioxide; survival time; cancer regression; promyelocytic leukemia; idarubicin; retinoic acid
Journal Title: Blood
Volume: 120
Issue: 8
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2012-08-23
Start Page: 1535
End Page: 1536
Language: English
DOI: 10.1182/blood-2012-07-439547
PROVIDER: scopus
PUBMED: 22918418
DOI/URL:
Notes: --- - "Export Date: 1 October 2012" - "CODEN: BLOOA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jae Hong Park
    356 Park